Q32 Bio (QTTB) Current Leases (2020 - 2023)
Q32 Bio (QTTB) recorded quarterly Current Leases of $1.3 million in Q4 2023, down 25.87% quarter-over-quarter from $1.8 million in Q3 2023, and down 15.57% on a YoY basis from $1.6 million in Q4 2022.
Q32 Bio (QTTB) Current Leases (2020 - 2023) Analysis & Trends
Q32 Bio's Current Leases history runs 4 years deep, the most recent figure standing at $1.3 million for Q4 2023.
- In Q4 2023, Current Leases fell 15.57% year-over-year to $1.3 million; the TTM figure through Dec 2023 stood at $1.3 million (down 15.57% YoY), while the FY2023 annual figure was $1.3 million, down 15.57% from the prior year.
- Current Leases was $1.3 million for Q4 2023 at Q32 Bio, down from $1.8 million in the prior quarter.
- In the past five years, Current Leases ranged from a high of $2.5 million in Q4 2020 to a low of $246000.0 in Q4 2021.
- Historically, Current Leases has averaged $1.7 million across 4 years, with a median of $1.7 million in 2023.
- The sharpest annual moves came in 2021 and 2022: Current Leases tumbled 90.16% in 2021, then soared 534.55% in 2022.
- A 4-year view of Current Leases shows it stood at $2.5 million in 2020, then sank by 90.16% to $246000.0 in 2021, then jumped by 534.55% to $1.6 million in 2022, then fell by 15.57% to $1.3 million in 2023.
- The last three Current Leases figures came in at $1.3 million (Q4 2023), $1.8 million (Q3 2023), and $1.7 million (Q2 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | 42,980.09 |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | - |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Q32 Bio | 177.18 Mn | 126.43 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 1.32 Mn |
| Sep 30, 2023 | 1.78 Mn |
| Jun 30, 2023 | 1.70 Mn |
| Mar 31, 2023 | 1.63 Mn |
| Dec 31, 2022 | 1.56 Mn |
| Sep 30, 2022 | 1.49 Mn |
| Jun 30, 2022 | 410,000.00 |
| Mar 31, 2022 | 435,000.00 |
| Dec 31, 2021 | 246,000.00 |
| Sep 30, 2021 | 1.96 Mn |
| Jun 30, 2021 | 2.14 Mn |
| Mar 31, 2021 | 2.32 Mn |
| Dec 31, 2020 | 2.50 Mn |
| Sep 30, 2020 | 2.50 Mn |
| Jun 30, 2020 | 2.41 Mn |
| Mar 31, 2020 | 2.33 Mn |